Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01511861|
Recruitment Status : Active, not recruiting
First Posted : January 19, 2012
Last Update Posted : December 1, 2016
Adequate glycemic control in patients with Diabetes Mellitus (DM) is a desired therapeutic goal that is difficult to achieve with current blood glucose monitoring technology. Home blood glucose monitoring (HBGM) technology, which requires finger pricking, is a source of severe inconvenience and hence, a lack of compliance.Thus, the need for non-invasive and easy to operate glucose monitoring in DM patients for strict glycemic control cannot be overemphasized.
The Glucometer GM-205 blood glucose readings are accurate and measure blood glucose with an acceptable mean relative error when compared to acceptable invasive blood glucose measurements.
The primary objectives of the trial are to determine:
- Assessing the reliability of the Glucometer GM-205 in evaluating blood glucose levels compare to the standard glucose blood test
- Creating database of glucose levels readings utilizing the Glucometer GM-205.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||137 participants|
|Official Title:||Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device|
|Study Start Date :||November 2010|
|Actual Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||January 2018|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01511861
|Edith Wolfson Medical Center|